Biochemical characterization of the soluble form of tumor antigen MUC1 isolated from sera and ascites fluid of breast and pancreatic cancer patients

Clinical Cancer Research

Volumn 7, Issue 11 SUPPL., 2001, Pages

  Beatty, Pamela ^a   Hanisch, Franz Georg ^b   Stolz, Donna Beer ^a   Finn, Olivera J ^a   Ciborowski, Pawel ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN; CARBOHYDRATE; CLOSTRIPAIN; CYSTEINE PROTEINASE; MONOSACCHARIDE; MUC1 MUCIN PEPTIDE; N ACETYLNEURAMINIC ACID; PEPTIDE FRAGMENT; SIALIDASE; TRYPSIN;

ARTICLE; ASCITES; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; BREAST TUMOR; CHEMISTRY; ELECTRON MICROSCOPY; ENDOSOME; GLYCOSYLATION; HUMAN; IMMUNOBLOTTING; METABOLISM; PANCREAS TUMOR; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN TERTIARY STRUCTURE;

ASCITES; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARBOHYDRATES; CYSTEINE ENDOPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOSOMES; GLYCOSYLATION; HUMANS; IMMUNOBLOTTING; MICROSCOPY, ELECTRON; MODELS, GENETIC; MONOSACCHARIDES; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; TRYPSIN;

EID: 0035287219     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Gendler, S. J., and Spicer, A. P. Epithelial cell mucins. Ann. Rev. Physiol., 57: 607-634, 1995.
2. Hanisch, F-G., Uhlenbruck, G., Peter-Katalinic, J., Egge, H., Dabrowski, J., and Dabrowski, U. Structures of neutral O-linked polylactosaminglycans on human skim milk mucins. J. Biol. Chem., 264: 872-883, 1989.
3. Lloyd. K. O., Burchell, J., Kudryshov, V., Yin, B. W. T., and Taylor-Papadimitriou, J. Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma lines. J. Biol. Chem., 277: 33325-33334, 1996.
4. Hanisch, F-G., Stadie, T. R. E., Deutzman, F., and Peter-Katalinic, J. MUC1 glycoforms in breast cancer. Cell line T47D as a model for carcinoma-associated alterations of O-glycosylation. Eur. J. Biochem., 236: 318-327, 1996.
5. Brockhausen, I., Yang, J. M., Burchell, J., Whitehouse, C., and Taylor-Papadimitriou, J. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur. J. Biochem., 233: 607-617, 1995.
6. Barrat Boyes, S. M. Making the most of mucin: a novel target for tumor immunotherapy. Cancer Immunol. Immunother., 43: 142-151, 1996.
7. Goydos, J. S., Elder, E., Whiteside, T. L., Finn, O. J., and Lotze, M. T. A Phase I trial of a synthetic mucin peptide vaccine. J. Surg. Res., 63: 298-304, 1996.
8. Lan, M. S., Khorrami, A., Kaufman, B., and Metzgar, R. S. Molecular characterization of a mucin-lype antigen associated with human pancreatic cancer. J. Biol. Chem., 262: 12863-12870, 1987.
9. Hiltbold, E. M., Vlad, A. M., Ciborowski, P., Watkins, S. C., and Finn, O. J. Mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. J. Immunol., 165: 3730-3741, 2000.
10. Burchell, J., Gendler, S., Taylor-Papadimitriou, J., Girling, A., Lewis, R., Millis, R., and Lamport, D. Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res., 47: 5476-5482, 1987.
11. Spencer, D. I. R., Price, M. R., Tendler, S. J. B., De Matteis, C. I., Stadie, T., and Hanisch, F-G. Effect of glycosylation of a synthetic MUC1 mucin-core-related peptide on recognition by anti-mucin antibodies. Cancer Lett., 100: 11-15, 1996.
12. Price, M. R. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. Tumor Biol., 19: 1-20, 1998.
13. Ciborowski, P., Konitzki, W., Magarian-Blander, J., and Finn, O. J. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes. Tumor Biol., 19: 147-151, 1998.
14. Ciborowski, P., and Finn, O. J. Recombinant epithelial cell mucin (MUC-1) expressed in baculovirus resembles antigenically tumor associated mucin, target for cancer immunotherapy. Biomed. Peptides Proteins Nucleic Acids, 1: 193-198, 1995.
15. Creeth, J. M., and Denborough, M. A. The use of equilibrium-density-gradient methods for the preparation and characterization of blood-group-specific glycoproteins. Biochem. J., 117: 879-891, 1970.
16. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 72: 304-311, 1970.
17. Stadie, T. R. E., Chai, W., Lawson, A. M., and Hanisch, F-G. Studies on the order and site specificity of GalNAc transfer to MUC1 tandem repeats by UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase from milk or mammary carcinoma cells. Eur. J. Biochem. 229: 140-147, 1995.
18. Wreschner, D. H., Hareuveni, M., Tsarfaty, I., Smorodinsky, N., Horev, J., Zaretsky, J., Kotkes, P., Weiss, M., Lathe, R., Dion, A., and Keydar, I. Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur. J. Biochem.. 189: 463-473, 1990.
19. Altschuler, Y., Kinlough, C. L., Poland, P. A., Burns, J. B., Apodaca, G., Weisz, O. A., and Hughey, R. P. Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. Mol. Biol. Cell, 11: 819-831, 2000.
20. Beum, P. V., Singh, J., Burdick, M., Hollingsworth, M. A., and Cheng, P-W. Expression of core 2β-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. J. Biol. Chem., 274: 24641-24648, 1999.
21. Muller, S., Alving, K., Peter-Katalinic, J., Zachara, N., Gooley, A. A., and Hanisch, F.-G. High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells. J. Biol. Chem., 274: 18165-18172, 1999.